LIANHE TECHNOLOGY(SZ:002250)2023-02-01 22:56Group 1: Investor Relations Activities - The investor relations activity was a targeted research event held on January 31, 2023, at the company's Shanghai office [1] - Participants included representatives from various financial institutions such as Tianfeng Securities and Zhongyin Securities [1] Group 2: Agricultural Protection Business - The new production capacity for the agricultural protection business is primarily located in Shandong and the UK [1] - The Jiangsu base's operational performance in 2022 was positively impacted by the global increase in agricultural product prices due to the Russia-Ukraine conflict, resulting in high utilization rates and good overall performance [1] Group 3: Pharmaceutical Projects - The pharmaceutical validation projects are progressing as planned, with some projects already completed and new validation projects being received [1] - Successful completion of these projects is expected to support growth in the pharmaceutical business in the coming years [1] Group 4: CRO Business Development - The company is expanding its CRO (Contract Research Organization) business to better meet customer needs and provide one-stop services [2] - The CRO laboratory in Shanghai is nearing completion, and the company is actively engaging with clients to explore business opportunities [2] Group 5: CDMO Business Outlook - The global agricultural terminal product market is valued at over $60 billion, with an annual growth rate of approximately 3%-5% [2] - The company focuses on serving leading agricultural enterprises and is exploring new areas such as soil health and biopesticides to ensure sustainable growth [2] Group 6: New Energy Business Development - The company has been focused on chemical synthesis and sees potential in the electronic chemicals sector as part of its future development strategy [2] - The battery chemicals project at the subsidiary Dezhou Lianhua is progressing according to plan, with installation and commissioning underway [2]